chlamydia vaccine investigational

Selected indexed studies

• An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial. (Lancet Infect Dis, 2024) [PMID:38615673]
• Combining Cellular Immunology With RNAseq to Identify Novel Chlamydia T-Cell Subset Signatures. (J Infect Dis, 2022) [PMID:35172331]

_Worker-drafted node — pending editorial review._